Pharmanutra Pharmanutra S.p.A.: le Novita SUI Mercati Esteri Stock: price and insider trades · Italy
Pharmanutra Pharmanutra S.p.A.: le Novita SUI Mercati Esteri: what insiders have been doing
Pharmanutra Pharmanutra S.p.A.: le Novita SUI Mercati Esteri has a thin disclosure history in our data (latest filing: 2 April 2025). New filings will appear here as soon as they are published. Source: insider filings from Consob. Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 8,119 of 26,911 companies
61.5
score / 100
Value38
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€83.00
Analyst consensus
3 analysts1.00/5
€76.00Target €81.33(-2%)€86.00
Income statement
Revenue€132.9M
Gross profit€102.9M77% margin
EBITDA€34.3M26% margin
Net income€20.0M15.1% margin
Valuation
PER (trailing)37.7x
PER (forward)27.1x
P/Book10.7x
Beta0.17
Balance sheet & cash
Market cap€794.7M
Total debt€20.5M
Free Cash Flow€16.4M
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.2%
% insiders65.0%
% institutions17.2%
Last declaration on 2 April 2025
Declarations1 total
- ●Executives0Consob
1 of 1 declaration
About Pharmanutra Pharmanutra S.p.A.: le Novita SUI Mercati Esteri
Pharmanutra S.p.a. is an Italian company operating in the health and pharmaceutical sector. It focuses on the development and marketing of nutraceutical and pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
